Latvia vs Libya: Cause of death, by non-communicable diseases, ages 5-14, female
Latvia
49.5%
in 2021
Libya
50.9%
in 2021
Latvia rank
63rd
Libya rank
60th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Latvia
- Libya
How they compare
Libya currently reports 50.9% against 49.5% in Latvia, a difference of 1.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Libya ahead.
Latvia ranks 63rd and Libya ranks 60th of 184 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Libya in 1.
Head to head by decade
| Decade | Latvia | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.1% | 50.4% | 3.3% | Libya |
| 2010s | 47.3% | 30.6% | 16.8% | Latvia |
| 2020s | 52.6% | 41.2% | 11.4% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Latvia or Libya?
- Libya, at 50.9% against 49.5% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Latvia and Libya?
- 1.4%, with Libya ahead.
- How many years of comparable data are there for Latvia and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Libya rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Latvia ranks 63rd and Libya ranks 60th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.